Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Galena Biopharma In (GALE)

Galena Biopharma In (GALE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,885
  • Shares Outstanding, K 45,710
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,550 K
  • 60-Month Beta 1.99
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.69
Trade GALE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.98
  • Most Recent Earnings -0.19 on 08/14/17
  • Next Earnings Date 11/08/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.58
  • Growth Rate Est. (year over year) +172,341.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.26 unch
on 12/29/17
0.40 -35.00%
on 12/29/17
-0.05 (-16.40%)
since 11/29/17
3-Month
0.26 unch
on 12/29/17
0.44 -40.91%
on 10/10/17
-0.09 (-26.35%)
since 09/29/17
52-Week
0.26 unch
on 12/29/17
2.41 -89.21%
on 02/06/17
-1.79 (-87.32%)
since 12/29/16

Most Recent Stories

More News
Keloid Treatment Market Size, Competition, Trends and Growth Opportunities by Region 2021-2028

Global Keloid Treatment Market is segmented based on the treatments type as, Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional...

AVMXY : 7.8900 (+9.13%)
BMY : 59.84 (unch)
GALE : 0.26 (-7.14%)
GSK : 38.05 (-1.17%)
NVS : 82.30 (-0.35%)
PRGO : 43.38 (+0.07%)
SNOA : 6.99 (+30.65%)
VRX.TO : 30.80 (-3.33%)
Keloid Treatment Market Trends, Esports Market Size Share And Structure 2021

Global Keloid Treatment Market is segmented based on the treatments type as, Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional...

AVMXY : 7.8900 (+9.13%)
BMY : 59.84 (unch)
GALE : 0.26 (-7.14%)
GSK : 38.05 (-1.17%)
NVS : 82.30 (-0.35%)
PRGO : 43.38 (+0.07%)
SNOA : 6.99 (+30.65%)
VRX.TO : 30.80 (-3.33%)
Worldwide Keloid Treatment Industry to 2026 - Featuring Renovo Group, Galena Biopharma and Novartis Among Others - ResearchAndMarkets.com

The "Keloid Treatment Market (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

GALE : 0.26 (-7.14%)
Keloid Treatment Market Share, Trends | Industry Overview 2021 to 2026

Global Keloid Treatment Market is segmented based on the treatments type as, Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional...

AVMXY : 7.8900 (+9.13%)
BMY : 59.84 (unch)
GALE : 0.26 (-7.14%)
GSK : 38.05 (-1.17%)
NVS : 82.30 (-0.35%)
PRGO : 43.38 (+0.07%)
SNOA : 6.99 (+30.65%)
VRX.TO : 30.80 (-3.33%)
Keloid Treatment Market Research With Size, Growth, Key Players, Segments And Forecasts Analysis 2021-2027

Global Keloid Treatment Market is segmented based on the treatments type as, Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional...

AVMXY : 7.8900 (+9.13%)
BMY : 59.84 (unch)
GALE : 0.26 (-7.14%)
GSK : 38.05 (-1.17%)
NVS : 82.30 (-0.35%)
PRGO : 43.38 (+0.07%)
SNOA : 6.99 (+30.65%)
VRX.TO : 30.80 (-3.33%)
Global Peptide Cancer Vaccine Market & Clinical Trials Insight to 2026 - Featuring Antigen Express, BioLife Science and Galena Biopharma Among Others - ResearchAndMarkets.com

The "Global Peptide Cancer Vaccine Market & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering.

GALE : 0.26 (-7.14%)
What are The Major Factors Expected to Limit The Growth Of The Keloid Treatment Market?

Global share consists of several players including Pacific World Corporation, Revitol Corporation Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Novartis AG, Renovo Group plc., Valeant Pharmaceuticals...

AVMXY : 7.8900 (+9.13%)
BMY : 59.84 (unch)
GALE : 0.26 (-7.14%)
GSK : 38.05 (-1.17%)
NVS : 82.30 (-0.35%)
PRGO : 43.38 (+0.07%)
SNOA : 6.99 (+30.65%)
VRX.TO : 30.80 (-3.33%)
Keloid Treatment Market Research Report by Device, by Service, by Industry – Global Forecast to 2025 – Cumulative Impact of COVID-19

Global share consists of several players including Pacific World Corporation, Revitol Corporation Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Novartis AG, Renovo Group plc., Valeant Pharmaceuticals...

AVMXY : 7.8900 (+9.13%)
BMY : 59.84 (unch)
GALE : 0.26 (-7.14%)
GSK : 38.05 (-1.17%)
NVS : 82.30 (-0.35%)
PRGO : 43.38 (+0.07%)
SNOA : 6.99 (+30.65%)
VRX.TO : 30.80 (-3.33%)
Keloid Treatment Market Share, Development by Companies Outlook, Growth Prospects and Key Opportunities by 2030

Global share consists of several players including Pacific World Corporation, Revitol Corporation Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Novartis AG, Renovo Group plc., Valeant Pharmaceuticals...

AVMXY : 7.8900 (+9.13%)
BMY : 59.84 (unch)
GALE : 0.26 (-7.14%)
GSK : 38.05 (-1.17%)
NVS : 82.30 (-0.35%)
PRGO : 43.38 (+0.07%)
SNOA : 6.99 (+30.65%)
VRX.TO : 30.80 (-3.33%)
Keloid Treatment Market Latest Research On Industry Growth, Trends, Top Players, & Key Regions By 2027

Global share consists of several players including Pacific World Corporation, Revitol Corporation Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Novartis AG, Renovo Group plc., Valeant Pharmaceuticals...

AVMXY : 7.8900 (+9.13%)
BMY : 59.84 (unch)
GALE : 0.26 (-7.14%)
GSK : 38.05 (-1.17%)
NVS : 82.30 (-0.35%)
PRGO : 43.38 (+0.07%)
SNOA : 6.99 (+30.65%)
VRX.TO : 30.80 (-3.33%)

Business Summary

Galena Biopharma, Inc. is a biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Galena Biopharma, Inc., formally known as RXi Pharmaceuticals Corporation, is based in Portland, Oregon.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.45
1st Resistance Point 0.35
Last Price 0.26
1st Support Level 0.21
2nd Support Level 0.17
3rd Support Level N/A

See More

52-Week High 2.41
Fibonacci 61.8% 1.59
Fibonacci 50% 1.34
Fibonacci 38.2% 1.08
Last Price 0.26
52-Week Low 0.26

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar